Chemoinformaics analysis of 1,2,3-TRI-O-GALLOYL-BETA-4C1-GLUCOSE
| Molecular Weight | 636.471 | nRot | 7 |
| Heavy Atom Molecular Weight | 612.279 | nRig | 27 |
| Exact Molecular Weight | 636.096 | nRing | 4 |
| Solubility: LogS | -2.643 | nHRing | 1 |
| Solubility: LogP | 0.789 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 3 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 18 | No. of Arom Bond | 18 |
| nHA | 18 | APOL | 75.529 |
| nHD | 11 | BPOL | 33.625 |
| QED | 0.09 |
| Synth | 4.296 |
| Natural Product Likeliness | 1.079 |
| NR-PPAR-gamma | 0.664 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.033 |
| Pgp-sub | 0.002 |
| HIA | 0.995 |
| CACO-2 | -6.889 |
| MDCK | 0.0000148 |
| BBB | 0.014 |
| PPB | 0.847291 |
| VDSS | 0.508 |
| FU | 0.179345 |
| CYP1A2-inh | 0.243 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.024 |
| CYP2c9-inh | 0.134 |
| CYP2c9-sub | 0.029 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.089 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.005 |
| CL | 10.25 |
| T12 | 0.969 |
| hERG | 0.03 |
| Ames | 0.063 |
| ROA | 0.002 |
| SkinSen | 0.945 |
| Carcinogencity | 0.012 |
| EI | 0.901 |
| Respiratory | 0.003 |
| NR-Aromatase | 0.604 |
| Antiviral | Yes |
| Prediction | 0.737167 |